NEW YORK (GenomeWeb News) – Intrexon has raised $66.9 million, according to a document filed with the US Securities and Exchange Commission last week.
Based in Blacksburg, Va., the genetic engineering firm did not say how the funds will be used but said the offering was not made in connection with a business combination transaction such as a merger.
A total of 82 investors participated in the offering, though Intrexon did not identify them. The company, which had been called Genomatix, said the date of the first sale for the offering was Feb. 19, 2010.
A company spokesman declined to comment on the transaction.
In January 2010, Intrexon raised $25 million in equity financing.